Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
02:30:19 EST Mon 10 Nov 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:HMTXF - HEMOSTEMIX INC - https://www.hemostemix.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
HMTXF - Qnot subscribed0.063-0.00288-4.44.0010.063  0.063  0.0630.285  0.043810:25:14Nov 0415 min RT 2¢

Recent Trades - All 1 today
Time ETExPriceChangeVolume
10:25:14Q0.063-0.002884,000
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-11-04 15:10U:HMTXFNews ReleaseHemostemix Closes Private Placement of $461,230
2025-10-30 11:30U:HMTXFNews ReleaseHemostemix's Boots on the Ground in Florida October Update
2025-10-28 15:45U:HMTXFNews ReleaseHemostemix Announces Its Webinar for Florida Vascular Surgeons: Autologous Stem Cell Therapy for CLTI
2025-10-22 10:05U:HMTXFNews ReleaseHemostemix Granted Trademark "KNOW YOUR HEALTH" in Japan, International Registration No. 1744775 Covers Stem Cell Preparations and Research in Classes 1, 5, 42
2025-10-15 15:52U:HMTXFNews ReleaseHemostemix Adds the Treatment of Refractory Angina to Its Phase 1 Basket Protocol
2025-10-09 09:04U:HMTXFNews ReleaseHemostemix Files for Ethics Approval of its Study of Vascular Dementia
2025-10-07 10:06U:HMTXFNews ReleaseHemostemix's Insider Lead Order of $330,000 Private Placement
2025-09-23 12:24U:HMTXFNews ReleaseHemostemix Files FDA Submission for Basket Protocol (Filing 1517) to Advance ACP-01 (VesCell(TM)) Across Multiple Ischemic and Vascular Indications Simultaneously
2025-09-17 07:53U:HMTXFNews ReleaseHemostemix to Present at Life Science Investor Forum
2025-09-16 14:53U:HMTXFNews ReleaseHemostemix to Present Its Clinical Data of the Treatment of Severe Angina
2025-09-10 16:38U:HMTXFNews ReleaseHemostemix Announces TSXV Approval of Debt Settlement at $0.20 per Share
2025-09-09 08:48U:HMTXFNews ReleaseHemostemix Announces Private Placement
2025-09-09 06:14U:HMTXFNews ReleaseHemostemix Launches Enhanced HubSpot-Powered Websites to Support Global Marketing & Sales of ACP-01 for No-Option Patients
2025-09-04 09:48U:HMTXFNews ReleaseHemostemix's VesCell.Health Launched in Florida
2025-09-03 08:48U:HMTXFNews ReleaseHowie's 17+ Years After VesCell(TM): Following Hemostemix's Heart Patients
2025-08-28 14:53U:HMTXFNews ReleaseHemostemix Announces Financing Plans for VesCell(TM) Treatment
2025-08-26 09:13U:HMTXFNews ReleaseHemostemix's Boots on the Ground in Florida
2025-08-20 07:36U:HMTXFNews ReleaseHemostemix's Social Media for Investors and Florida's No-Option Patients
2025-08-19 06:55U:HMTXFNews ReleaseHemostemix Announces Its AI Strategy
2025-08-14 09:18U:HMTXFNews ReleaseHemostemix's Expands its Marketing Team Focused on Sales in Florida